Literature DB >> 25338991

Prognostic significance of the mucin component in stage III rectal carcinoma patients.

Meng Wang1, Yuan-Chuan Zhang, Xu-Yang Yang, Zi-Qiang Wang.   

Abstract

BACKGROUND: Although mucinous adenocarcinoma has been recognized for a long time, whether it is associated with a poorer prognosis in colorectal cancer patients is still controversial. Many studies put emphasis on mucinous adenocarcinoma containing mucin component ≥50%. Only a few studies have analyzed cases with a mucin component <50%.
OBJECTIVES: This study aimed to analyze the prognostic value of different mucin component proportions in patients with stage III rectal cancer.
MATERIALS AND METHODS: Clinical, pathological and follow-up data of 136 patients with the stage III rectal cancer were collected. Every variable was analyzed by univariate analysis, then multivariate analysis and survival analysis were further performed.
RESULTS: Univariate analysis showed pathologic T stage, lymphovascular invasion, and histological subtype were statistically significant for DFS. Pathologic T stage was significant for OS. Histological subtype and lymphovascular invasion were independent prognostic factors in multivariate analysis for DFS, and histological subtype was the only independent prognostic factor for OS. Survival curves showed the survival time of mucinous adenocarcinoma (MUC) was shorter than non-MUC (adenocarcinomas with a mucin component <50% and without mucin component).
CONCLUSIONS: Histological subtype (tumor with different mucin component) was an independent prognostic factor for both DFS and OS. Patients with MUC had a worse prognosis than their non-MUC counterparts with stage III rectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25338991     DOI: 10.7314/apjcp.2014.15.19.8101

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer.

Authors:  Gurbet Korkmaz; Cem Horozoglu; Soykan Arıkan; Zeynep Gural; Esra Kaytan Sağlam; Saime Turan; Nazlı Ezgi Özkan; Ozlem Timirci Kahraman; Ezgi Nurdan Yenilmez; Yigit Düzköylü; Mehmet Baki Doğan; Umit Zeybek; Arzu Ergen; İlhan Yaylım
Journal:  Bosn J Basic Med Sci       Date:  2016-02-04       Impact factor: 3.363

Review 2.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

3.  Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.

Authors:  Jian Zhao; Jian Xu; Rui Zhang
Journal:  Med Sci Monit       Date:  2017-10-08

4.  Mucinous and Non-Mucinous Rectal Adenocarcinoma-Differences in Treatment Response to Preoperative Radiotherapy.

Authors:  Karolina Vernmark; Xiao-Feng Sun; Annica Holmqvist
Journal:  J Pers Med       Date:  2020-11-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.